tiprankstipranks
Chill Brands Group PLC (GB:CHLL)
LSE:CHLL
Want to see GB:CHLL full AI Analyst Report?

Chill Brands Group PLC (CHLL) AI Stock Analysis

6 Followers

Top Page

GB:CHLL

Chill Brands Group PLC

(LSE:CHLL)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
0.41 p
▼(-47.95% Downside)
Action:ReiteratedDate:04/28/26
The score is driven primarily by very weak financial performance (ongoing losses, negative free cash flow, and negative equity with debt), which outweighs the benefit of recent revenue growth. Technicals also remain soft with the stock trading below major moving averages and negative MACD. Valuation is constrained by negative earnings and no dividend support.
Positive Factors
Revenue Growth Trajectory
Material top-line growth (~310% YoY to 370,501) signals meaningful market demand and initial product traction in the cannabinoid/wellness category. Durable demand expansion supports prospects for scale, distribution leverage and the potential to dilute fixed costs as revenue rises.
Negative Factors
Negative Gross Profit and Deep Losses
Persistently negative gross profit means product costs exceed revenue at the unit level, a fundamental profitability shortfall. Without restoring positive gross margins via pricing, cost reduction, or mix change, scaling revenue alone will not produce sustainable profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Trajectory
Material top-line growth (~310% YoY to 370,501) signals meaningful market demand and initial product traction in the cannabinoid/wellness category. Durable demand expansion supports prospects for scale, distribution leverage and the potential to dilute fixed costs as revenue rises.
Read all positive factors

Chill Brands Group PLC (CHLL) vs. iShares MSCI United Kingdom ETF (EWC)

Chill Brands Group PLC Business Overview & Revenue Model

Company Description
Chill Brands Group PLC engages in the research, development, production, and sale of cannabidiol (CBD) consumer products and other lifestyle goods in the United States and the United Kingdom. The company offers tobacco alternative products, includ...
How the Company Makes Money
null...

Chill Brands Group PLC Financial Statement Overview

Summary
Financial quality is very weak: despite sharp revenue growth, gross profit remains negative, losses are large (net income -2,884,747), operating/free cash flow are deeply negative (FCF -2,354,660), and equity is negative (-1,234,074) with meaningful debt (2,661,757), elevating solvency and funding risk.
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
14
Very Negative
BreakdownMar 2026Mar 2025Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue370.50K305.70K1.91M624.19K320.88K
Gross Profit-403.24K-395.58K472.81K-778.81K-40.64K
EBITDA-2.41M-2.88M-2.75M-5.46M-4.78M
Net Income-2.88M-3.30M-3.37M-5.71M-4.85M
Balance Sheet
Total Assets2.14M2.13M5.27M3.26M1.76M
Cash, Cash Equivalents and Short-Term Investments99.96K30.95K1.32M420.05K333.18K
Total Debt2.66M1.74M1.81M337.02K80.42K
Total Liabilities3.37M2.86M2.69M1.72M1.99M
Stockholders Equity-1.23M-731.00K2.57M1.54M-224.18K
Cash Flow
Free Cash Flow-2.35M-1.22M-4.19M-5.61M-985.99K
Operating Cash Flow-2.35M-1.22M-4.19M-4.96M-984.64K
Investing Cash Flow-4.49K-982.000.00-644.64K300.54K
Financing Cash Flow1.14M-66.89K1.74M5.64M623.25K

Chill Brands Group PLC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
£31.14B20.156.43%1.51%-1.81%17.54%
60
Neutral
£74.92M2.807.82%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
£94.56M-4.82206.44%49.81%52.94%
45
Neutral
£690.25M-7.21409.00%2.94%-32.00%
45
Neutral
£22.05M-11.67-51.21%-27.38%-50.00%
41
Neutral
£2.22M-2.77
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CHLL
Chill Brands Group PLC
0.45
-1.70
-79.26%
GB:AGY
Allergy Therapeutics
10.30
3.40
49.28%
GB:PXS
Provexis
1.03
0.45
79.20%
GB:STX
Shield Therapeutics
8.85
6.50
276.60%
GB:VLG
Venture Life
58.60
17.60
42.93%
GB:HLN
Haleon PLC
350.80
-19.31
-5.22%

Chill Brands Group PLC Corporate Events

Business Operations and Strategy
Chill Brands expands UK convenience reach and explores chill.com digital platform partnerships
Positive
Apr 23, 2026
Chill Brands Group reported progress at its Chill Connect direct-to-convenience distribution arm, which has expanded its product range beyond vaping and nicotine alternatives into beverages, confectionery, batteries, and other adjacent FMCG catego...
Business Operations and StrategyShareholder MeetingsStock Split
Chill Brands Seeks Share Capital Revamp to Restore Fundraising Flexibility
Neutral
Apr 20, 2026
Chill Brands Group has called a reconvened 2024 annual general meeting and its 2025 AGM for 13 May 2026 in London, where shareholders will vote on approval of past accounts, director remuneration, auditor appointment and director re-election, alon...
Business Operations and StrategyExecutive/Board Changes
Chill Brands Director Steps Down as Board Reviews Committee Structure
Neutral
Mar 31, 2026
Chill Brands Group has announced the immediate resignation of Non-Executive Director Nick Tulloch, who is stepping down to concentrate on his other business interests. The board has thanked Tulloch for his contribution and said it will review the ...
Business Operations and StrategyFinancial Disclosures
Chill Brands accelerates revenue growth as Chill Connect outpaces UK convenience demand
Positive
Feb 9, 2026
Chill Brands reported strong momentum at its Chill Connect distribution platform, with product sales revenue growing more than 55% month-on-month on average between October 2025 and January 2026. Combined monthly revenues from product sales and se...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Chill Brands Posts Extended 18-Month Results After Governance Turmoil and Strategic Reset
Negative
Jan 30, 2026
Chill Brands Group has released its audited final results for an extended 18‑month financial period to 30 September 2025, reflecting a highly unusual and transitional phase marked by governance disruption, operational challenges and a strate...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 28, 2026